Logo

Metabolon to Collaborate with Mass General on ALS Biomarker Study

Aug 09, 2004

NEW YORK, Aug. 9 (GenomeWeb News) - Metabolon said today that it is collaborating with Massachusetts GeneralHospital on an amyotrophic lateral sclerosis biomarker study.

 

Under the collaboration, researchers from Metabolon and Mass General will work on identifying unique metabolic signatures for ALS as a means of developing a diagnostic test using biomarkers in cerebrospinal fluid and blood, the company said.

 

The study, being funded by the National Institute of Neurological Disorders and Stroke, is called Metabolic Signatures in ALS. Specific details of the Mass General collaboration were not disclosed.

 

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.